Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Radiother Oncol. 2023 Jul 31;187:109824. doi: 10.1016/j.radonc.2023.109824

Table 1.

Baseline patient characteristics

No. (%)
Total 66
Sex
 Male 31 (48%)
 Female 35 (52%)
Age, median (years) 58
KPS
 90 – 100 39 (59%)
 70 – 80 26 (39%)
 ≤ 60 1 (1%)
Oligometastatic*
 Yes 36 (55%)
 No 30 (45%)
Intrathoracic only disease*
 Yes 33 (50%)
 No 33 (50%)
Prior systemic therapy*
 Yes 61 (92%)
 No 5 (8%)
Courses of SBRT, median (range)
Histology**
 Leiomyosarcoma 19 (29%)
 Undifferentiated pleomorphic sarcoma 10 (15%)
 Liposarcoma 7 (11%)
 Osteosarcoma 7 (11%)
 Synovial 5 (8%)
 Other 18 (27%)
*

At time of first course of lung SBRT

**

Other disease histologies include: Ewing (n = 4), chondrosarcoma (n = 3), myxofibrosarcoma (n = 2), glomangiosarcoma (n = 2), epithelioid (n = 2), peripheral nerve sheath (n = 2), alveolar (n = 1), undifferentiated with epithelioid and myxoid features (n = 1), perivascular epithelioid cell Tumor (n = 1)